Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Adult-onset MELAS Syndrome Mimicking Autoimmune Encephalitis
Autoimmune Neurology
P10 - Poster Session 10 (8:00 AM-9:00 AM)
9-001

The clinical syndrome of MELAS is a rare mitochondrial disorder caused by mutations in mitochondrial DNA. The syndrome has variable manifestations which may include migraines, seizures, myopathy, hearing loss, and stroke-like events. The disease primarily affects those under the age of 40 years and may not be initially considered in older adults presenting with these symptoms.

To report a case of adult-onset mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), highlighting how the diagnosis may mimic an autoimmune or infectious encephalitis.

We present the case of a 59 year old male who initially presented with seizures and altered mental status with brain MRI revealing left hemispheric restricted diffusion. He was diagnosed with a viral encephalitis and his symptoms moderately improved with anti-epileptic agents and a 21 day course of IV acyclovir. Over the course of four years, he had several additional episodes of seizures and stroke-like events with work-up revealing similar imaging patterns involving other areas of the brain. He was ultimately diagnosed with seronegative autoimmune encephalitis and started on multiple immunosuppressive therapies including plasma exchange, intravenous immunoglobulin, and anti-CD20 monoclonal antibody therapy. Despite these treatments, he had continued disease progression which prompted re-evaluation of his diagnosis. He subsequently underwent repeat neuroimaging, cerebrospinal fluid analysis, and genetic testing.

His CSF analysis revealed elevated lactate and pyruvate level and MR brain spectroscopy confirmed a significant lactate peak within affected regions of the brain. Ultimately, he underwent mitochondrial genomic sequencing which revealed a pathogenic mutation associated with MELAS.

The clinical manifestations of MELAS are diverse and may appear to mimic those of an infectious or autoimmune encephalitis. Although this syndrome typically affects children and young adults, it should be considered in adult patients with presumed encephalitis that does not respond to appropriate therapy as expected.

Authors/Disclosures
Rumyar V. Ardakani, MD (Neuro-Infectious Diseases Group)
PRESENTER
Dr. Ardakani has nothing to disclose.
Lauren Tardo, MD (UT Southwestern Medical Center) Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NeurologyLive. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a Panel member with CanDoMS. Dr. Tardo has a non-compensated relationship as a Tardo with The MOG Project that is relevant to AAN interests or activities.
Benjamin M. Greenberg, MD, FAAN (UT Southwestern Medical Center) Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/ROche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Carlton Fields. Dr. Greenberg has stock in GenrAb. Dr. Greenberg has stock in Clene. The institution of Dr. Greenberg has received research support from Anokion. The institution of Dr. Greenberg has received research support from Regeneron. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Jaya R. Trivedi, MD, FAAN (UT Southwestern Medical Center) Dr. Trivedi has nothing to disclose.
Paula Hardeman (UT Southwestern Medical Center) Ms. Hardeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Ms. Hardeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio.
Elisabeth Golden, MD (University of Texas Health Science Center Tyler) Dr. Golden has nothing to disclose.